Ovid Therapeutics Inc
SWB:1OT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Ovid Therapeutics Inc
SWB:1OT
|
US |
|
Synergie SE
PAR:SDG
|
FR |
|
M
|
Mari Energies Ltd
KAR:MARI
|
PK |
|
G
|
GlaxoSmithKline Pakistan Ltd
KAR:GLAXO
|
PK |
|
M
|
Micro Leasing PCL
SET:MICRO
|
TH |
|
Inhibrx Inc
NASDAQ:INBX
|
US |
Wall St Price Targets
1OT Price Targets Summary
Ovid Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
1OT is 5.73 EUR with a low forecast of 4.13 EUR and a high forecast of 7.51 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1OT's stock price target?
Price Target
5.73
EUR
According to Wall Street analysts, the average 1-year price target for
1OT is 5.73 EUR with a low forecast of 4.13 EUR and a high forecast of 7.51 EUR.
What is the Revenue forecast for Ovid Therapeutics Inc?
Projected CAGR
76%
The compound annual growth rate for Revenue over the next 8 years is 76%.